Newsroom

香港--(BUSINESS WIRE)--（ビジネスワイヤ） -- オアシス・マネジメント・カンパニー・リミテッド（以下「オアシス」）は、製薬会社であり食品製造会社である、小林製薬株式会社（以下「小林製薬」または「同社」）（証券コード：4967 JT）の株式を 13.1％以上保有するファンドの運用会社です。 小林製薬の最大の株主であるオアシスは、小林製薬のコーポレートガバナンスおよび内部統制体制（特に品質保証体制）の改善を目的として、過去数年にわたり同社との建設的なエンゲージメントを積極的に行ってきました。その一環として、2025年2月には臨時株主総会（以下「臨時株主総会」）の招集請求を行い、また紅麹事件当時の取締役らに対して株主代表訴訟を提起しました。しかしながら、オアシスは、小林製薬のコーポレートガバナンス改革は未だ完了していないと考えています。小林製薬は依然として創業家の影響を受け続けており、品質保証体制も、直近の製品回収発表が示すとおり、十分に実効性をもって整備されていません。 これら小林製薬の継続的な課題に対処するため、オアシスは責任ある株主として、2026年3月開催予定の...

HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own over 13.1% of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT) (“Kobayashi Pharma” or the “Company”). Oasis, the largest shareholder of Kobayashi Pharma, has been actively engaging with the Company over the last several years to improve its corporate governance and internal control system, with a focus on its quality assurance meas...

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today plans to release fourth quarter 2025 results after market close on Wednesday, February 18. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EST on Thursday, February 19. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 93473. A webcast of the call can be accessed by visiting Nutrien’s Investor Events and Presentation pag...

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Fermi Inc. (“Fermi” or the “Company”) (NASDAQ:FRMI) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Fermi investments, you have until March 6, 2026 to request lead plaintiff appointment. Courts do not consider...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Navan, Inc. (“Navan” or the “Company”) (NASDAQ:NAVN) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On October 30, 2025, Navan conducted its initial public offering, selling approximately 36.9 million shares at $25.00 per sh...

BOSTON--(BUSINESS WIRE)--BXP (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today the 2025 tax treatment of distributions on shares of its common stock, as described below. Shareholders are encouraged to consult with their personal tax advisors as to the specific tax treatment to them of these distributions. Common Shares (CUSIP #101121101) Record Date Payment Date Total Distribution per Share Total Distribution Alloc...

BREA, Calif.--(BUSINESS WIRE)--Check N’ Play, a modern, emotionally enriching, screen-free play space and café for children ages six and under and the caregivers who support them has launched its flagship location at Brea Mall and will celebrate with an official ribbon-cutting ceremony on Wednesday, Jan. 28, 2026, from 3 to 4 p.m. in partnership with the Brea Chamber of Commerce. Located on the upper level of Brea Mall—a Simon Property Group destination—across from Zara Man, the 6,000-square-fo...

NEW YORK & LONDEN--(BUSINESS WIRE)--Balena, het toonaangevende platform voor het ontwikkelen, beheren en uitbouwen van vloten edge computing- en AI-apparaten, maakte vandaag een strategische groei-investering bekend van LoneTree Capital (“LoneTree”), een verschaffer van groeikapitaal gevestigd in New York. Dit partnerschap zal Balena’s productinnovatie versnellen, met focus op Edge AI-workloads en beveiligingsfuncties teneinde te voldoen aan de evoluerende behoeften op het vlak van naleving, te...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, une organisation de recherche sous contrat (CRO) internationale et filiale de JSR Life Sciences, a annoncé aujourd'hui que son laboratoire de San Diego a obtenu l'accréditation du College of American Pathologists (CAP). Cette étape importante s'ajoute à la certification CLIA (Clinical Laboratory Improvement Amendments) obtenue en juillet 2025, renforçant ainsi sa capacité à réaliser des analyses de biomarqueurs de qualité clinique destinées à souten...

NEW YORK & LONDRES--(BUSINESS WIRE)--Balena, la principale plateforme de déploiement, de gestion et de mise à l'échelle de flottes d'appareils d'informatique de pointe et d'intelligence artificielle, a annoncé aujourd'hui un investissement stratégique de croissance de la part de LoneTree Capital (« LoneTree »), une société de capital-risque basée à New York. Ce partenariat permettra d'accélérer l'innovation produit de Balena en mettant l'accent sur les charges de travail Edge AI et les fonction...